Shardul Amarchand Mangaldas (SAM), AZB & Partners and Kanga & Co advised on Anupam Rasayan’s acquisition of a 50.07% stake in Bliss GVS Pharma.
Anupam Rasayan India Limited, together with its wholly owned subsidiary Mates Visa Consultancy Private Limited, acquired a controlling stake of 50.07% in Bliss GVS Pharma Limited for an aggregate consideration of approximately INR 1,687.23 crore.
The acquisition was undertaken through a share purchase agreement, a mandatory open offer and on-market purchases. The transaction was financed through a bespoke private credit structure involving Investec India, Bain Capital, Tata Capital, Trust Capital and Aditya Birla Capital.
Shardul Amarchand Mangaldas & Co. (SAM) advised Anupam Rasayan India Limited and Mates Visa Consultancy Private Limited on the acquisition.
The transaction team comprised Partner Anirban Bhattacharya, Principal Associate Jeel Panchal, Senior Associate Pundrikaksh Sharma and Associate Yashwanth Samayam.
The securities law team comprised Partner Yogesh Chande, Principal Associate Preeti Kapany and Associate Ritvik Mishra. The financing team comprised Partner and Co-Head of the Banking & Finance Practice Veena Sivaramakrishnan, Principal Associate Yash Kahandole, Senior Associates Shubhra Baghel and Gaurav Karwa, and Associates Shruti Mishra, Dhruv Bhartia and Bhawini Jha.
AZB & Partners advised a consortium of lenders, including Investec India, Bain Capital, Tata Capital, Trust Capital and Aditya Birla Capital, on approximately INR 2,000 crore of structured private credit for Anupam Rasayan’s acquisition of a stake in Bliss GVS Pharma.
The team comprised Anand Shah, Shivanand Nayak, Prasham Shah, Devavrat Nimbalkar, Vedant Heda, Isha Kulkarni, Palomi Visaria, Abhilash Chandran, Aayush Raman, Yashvi Bhagat and Mehar Kalra.
Kanga & Co. Advised the sellers on the transaction.
The team was led by Senior Partner Chetan Thakkar, with support from Senior Associate Jalees Shaikh on the transaction documents, and Principal Associate Tejal Patankar, along with Associates Sachi Ray, Vansh Chadha, Suphla Singh and Meghna Sharma, on the open offer and securities law-related aspects.